Microbiology
-
The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID‐19 infections
This article has 7 authors:Reviewed by ScreenIT
-
SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients
This article has 17 authors:Reviewed by ScreenIT
-
Mapping the Immunodominance Landscape of SARS-CoV-2 Spike Protein for the Design of Vaccines against COVID-19
This article has 20 authors:Reviewed by ScreenIT
-
STAT2 signaling as double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-2 infected hamsters
This article has 51 authors:Reviewed by ScreenIT
-
Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect after a Drug Repurposing Screen
This article has 17 authors:Reviewed by ScreenIT
-
ACE2 polymorphisms and individual susceptibility to SARS-CoV-2 infection: insights from an in silico study
This article has 6 authors:Reviewed by ScreenIT
-
Critical role of type III interferon in controlling SARS-CoV-2 infection, replication and spread in primary human intestinal epithelial cells
This article has 9 authors:Reviewed by ScreenIT
-
The anticoagulant nafamostat potently inhibits SARS-CoV-2 infection in vitro : an existing drug with multiple possible therapeutic effects
This article has 14 authors:Reviewed by ScreenIT
-
Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2
This article has 12 authors:Reviewed by ScreenIT
-
Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2
This article has 25 authors:Reviewed by ScreenIT